Digital transformation has affected the clinical phase of the drug development journey by improving efficiencies, patient engagement and allowing for utilization of computational and other technologies. This track will address topics such as data collection, flow, storage and analytics and digital transformation case studies in clinical phase and the potential for digital transformation in preclinical phase. Preclinical in vivo phase is in initial stages of engaging with digitization and digitalization, which presents opportunities for learning from clinical colleagues how to implement these technologies.
Date: February 07, 2019
Category: NewsShare This